Genetic testing analyzes DNA to identify inherited conditions, disease risks, and genetic variations. It helps with early diagnosis, preventive healthcare, personalized treatment planning, and informed family planning decisions.

Genetic testing may be beneficial for individuals with a family history of inherited diseases, cancer, infertility, recurrent pregnancy loss, unexplained medical conditions, or those planning a family.

Most genetic tests require a simple blood sample or saliva sample. The collected sample is analyzed in a specialized laboratory using advanced genomic technologies.

Turnaround times vary depending on the test. Most genetic and genomic tests are completed within 2 to 4 weeks, while some specialized analyses may require additional time.

Your reports will be delivered digitally via WhatsApp or email, ensuring quick and easy access anytime, anywhere.

A Hereditary Cancer Panel is a genetic test that identifies inherited gene mutations associated with increased cancer risk. It helps individuals understand their genetic predisposition and take preventive healthcare measures.

Yes, our staff follows strict safety guidelines, including the use of gloves, masks, and sterilized equipment for every sample collection.

Yes, we offer flexible scheduling, including weekend availability. Please confirm your preferred time while booking.

A biopsy specimen(paraffin blocks and slides): a sample of tissue or cells removed from a living body to be examined under a microscope for diagnosing diseases, such as cancer, infections, or inflammation.

In a biopsy, a provider removes samples of your tissue, cells or fluids so a medical pathologist can examine them for signs of disease.

Oncogenomics studies the genetic changes within cancer cells to identify targeted treatment options, predict treatment response, and support precision cancer care.

Also known as conization or cold knife biopsy, providers do cone biopsies to remove abnormal tissue from your cervix. Cone biopsies may detect cervical cancer or cervical dysplasia that could lead to cancer.

NIPT is a prenatal screening test that analyzes fetal DNA present in the mother's blood to assess the risk of common chromosomal conditions, including Down syndrome, as early as 9–10 weeks of pregnancy.

Carrier screening helps determine whether prospective parents carry genetic variants that could be passed to their children. Early identification supports informed reproductive and family planning decisions.

HLA (Human Leukocyte Antigen) typing evaluates genetic compatibility between organ donors and recipients, helping reduce the risk of transplant rejection and improve transplant success.

RaktGen Works combines advanced laboratory technologies, expert scientific interpretation, reliable reporting, and comprehensive diagnostic solutions to support accurate diagnosis and personalized healthcare decisions.